Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hokkaido Reishi is a Japanese biotechnology and nutraceutical company specializing in the cultivation and processing of medicinal mushrooms, specifically the "Deer Horn Reishi" (Rokkaku Reishi). Based in Sapporo, the company utilizes proprietary indoor cultivation techniques that prevent spore release, resulting in Reishi with significantly higher concentrations of beta-glucans and triterpenes compared to standard varieties. Their business model integrates the entire production cycle, including research, cultivation, extraction, and the manufacturing of functional foods and dietary supplements. Hokkaido Reishi actively collaborates with academic institutions, such as Hokkaido University, to validate the pharmacological benefits of their products in areas like immunology and oncology support. The company's products are marketed globally, targeting consumers seeking natural therapeutic interventions for immune health and general wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hokkaido Reishi.